| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V36612 | (Ala11,D-Leu15)-Orexin B (human) | 532932-99-3 | [Ala11,D-Leu15]-Orexin B(human) is a potent and specific orexin-2 receptor (OX2) agonist. |
|
V36916 | (Ala286)-Calmodulin-Dependent Protein Kinase II (281-302) | (Ala286)-Calmodulin-Dependent Protein Kinase II (281-302) is a peptide compound. | |
|
|
V36408 | (Arg8)-Conopressin G | 130836-24-7 | (Arg8)-Conopressin G is a peptide compound. |
|
V36973 | (Asp76)-pTH (39-84) (human) | 79804-72-1 | (Asp76)-pTH (39-84) (human) is a bioactive peptide discovered by peptide screening. |
|
|
V36868 | (Cys2)-Neuropeptide Y (1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32)|C2-NPY | 128806-04-2 | (Cys2)-Neuropeptide Y (1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32)|C2-NPY is a peptide compound. |
|
V36808 | (D-Ala2)-GRF (1-29) amide (human) | 89453-59-8 | (D-Ala2)-GRF (1-29) amide (human) is a superagonist of GRF and displays extremely high GH-releasing activity in pigs and rats, about 50 times that of GRF (1-29). |
|
|
V37093 | (D-Ala2,Hyp4,Tyr5)-β-Casomorphin (1-5) amide | 102029-98-1 | (D-Ala2,Hyp4,Tyr5)-β-Casomorphin (1-5) amide is a peptide compound. |
|
|
V36714 | (D-Ala3)-Dynorphin A (1-11) amide | 160522-58-7 | (D-Ala3)-Dynorphin A (1-11) amide is a peptide compound. |
|
V37040 | (D-Arg1,D-Pro2,D-Trp7·9,Leu11)-Substance P | 84676-91-5 | (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P is an antagonist of the neuropeptide Substance P. |
|
|
V36716 | (D-Arg6)-Dynorphin A (1-13)|[D-Arg6]-Dynorphin A (1-13),porcine | 75921-87-8 | (D-Arg6)-Dynorphin A (1-13)|[D-Arg6]-Dynorphin A (1-13),porcine is a peptide compound. |
|
V37004 | (D-Phe7)-Somatostatin-14 | 64813-74-7 | (D-Phe7)-Somatostatin-14 is a bioactive peptide discovered by peptide screening. |
|
|
V36866 | (D-Trp32)-Neuropeptide Y (porcine) | 153549-78-1 | (D-Trp32)-Neuropeptide Y (porcine) is a peptide compound. |
|
|
V34890 | (Des-Asp1)-Angiotensin I | 56317-01-2 | (Des-Asp1)-Angiotensin I is a peptide compound. |
|
V36800 | (Des-Thr7)-Glucagon | 1802078-28-9 | (Des-Thr7)-Glucagon is a bioactive peptide discovered by peptide screening. |
|
|
V36376 | (Fmoc-Glu70,Ala71·72,Lys74)-C3a (70-77) | (Fmoc-Glu70,Ala71·72,Lys74)-C3a (70-77) is a peptide compound. | |
|
|
V36493 | (Glu8·9)-Helodermin | 209340-47-6 | (Glu8·9)-Helodermin is a peptide compound. |
|
|
V36882 | (His32,Leu34)-Neuropeptide Y (32-36) | 168916-68-5 | (His32,Leu34)-Neuropeptide Y (32-36) is a peptide compound. |
|
|
V36649 | (Lys18)-Pseudin-2 | (Lys18)-Pseudin-2 is a peptide compound. | |
|
|
V36703 | (Lys7)-Dermorphin | 142689-18-7 | (Lys7)-Dermorphin is a peptide compound. |
|
|
V36836 | (Met5,Pro6,D-Phe7,D-Trp9,Phe10)-α-MSH (5-13) | (Met5,Pro6,D-Phe7,D-Trp9,Phe10)-α-MSH (5-13) is a peptide compound. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
